Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Moammal Qurt"'
Autor:
Hani Naseef, Mosab Afaneh, Moammal Qurt, Abdullah Rabba, Abdallah Abukhalil, Numan Malkieh, Maher Kharouf, Ramzi Moqadi
Publikováno v:
Talanta Open, Vol 9, Iss , Pp 100298- (2024)
Rivaroxaban and aspirin are commonly used antithrombotic agents in combination to prevent coronary artery disease (CAD) and atherothrombotic events in adult patients after acute coronary syndrome (ACS) with elevated cardiac biomarkers, or with corona
Externí odkaz:
https://doaj.org/article/1309a73a09de4600903e728379745969
Autor:
Anwar Ma’ali, Hani Naseef, Moammal Qurt, Abdallah Damin Abukhalil, Abdullah K. Rabba, Israr Sabri
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1412 (2023)
Cobalamin (vitamin B12), an essential vitamin with low oral bioavailability, plays a vital role in cellular functions. This research aimed to enhance the absorption of vitamin B12 using sublingual mucoadhesive tablets by increasing the residence time
Externí odkaz:
https://doaj.org/article/4e1a8ba14dd54e5aa7867de072ff3671
Autor:
Moammal Qurt, Rania Eshtayyeh, Hani Naseef, Abdullah Rabba, Abdallah Damin Abukhalil, Numan Malkieh, Maher Kharouf
Publikováno v:
International Journal of Analytical Chemistry, Vol 2023 (2023)
Favipiravir is a broad-spectrum oral antiviral agent and has been approved for the treatment of COVID-19 infection cases. It inhibits a protein known as RNA polymerase, which transcribes and replicates the viral RNA genome, causing the spread of the
Externí odkaz:
https://doaj.org/article/8dbeefab3aa54ea5adf22d5cfcd51f77
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 39 (2022)
Vitamin D3 is available in oral and injectable dosage forms. Interest in the transdermal route as an alternative to the oral and parenteral routes has grown recently. In this study, several film-forming solutions for the transdermal delivery of vitam
Externí odkaz:
https://doaj.org/article/e36db0d430ec4d1b8aee56e052280926
Autor:
Hani Naseef, Yousef Sahoury, Mohammad Farraj, Moammal Qurt, Abdallah D. Abukhalil, Nidal Jaradat, Israr Sabri, Abdullah K. Rabba, Mahmmoud Sbeih
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1638 (2022)
Background: Drug design and development to overcome antimicrobial resistance continues to be an area of research due to the evolution of microbial resistance mechanisms and the necessity for new treatments. Natural products have been used since the d
Externí odkaz:
https://doaj.org/article/016972209bcb4237a9702f731cf78d87
Publikováno v:
Journal of Analytical Methods in Chemistry, Vol 2018 (2018)
Alogliptin benzoate, a member of dipeptidyl peptidase-4 inhibitors, is a recent drug developed by Takeda Pharmaceutical Company for the treatment of Type 2 diabetes; it potentiates the effect of incretin hormones through the inhibition of their degra
Externí odkaz:
https://doaj.org/article/f2b412812d6747c0bace0bf03b264d9c
Publikováno v:
International Journal of Pharmaceutical Research. 13
Article published in : International Journal of Pharmaceutical Research, Jan-Mar 2021, vol. 13, issue 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::883dbb81b074d536fda834b5a98276ab
https://doi.org/10.31838/ijpr/2021.13.01.178
https://doi.org/10.31838/ijpr/2021.13.01.178
Publikováno v:
Journal of Analytical Methods in Chemistry, Vol 2018 (2018)
Journal of Analytical Methods in Chemistry
Journal of Analytical Methods in Chemistry
Alogliptin benzoate, a member of dipeptidyl peptidase-4 inhibitors, is a recent drug developed by Takeda Pharmaceutical Company for the treatment of Type 2 diabetes; it potentiates the effect of incretin hormones through the inhibition of their degra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::435dca8efb6c52aeec2c06461fa0c474